SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-006626
Filing Date
2023-03-07
Accepted
2023-03-07 06:49:47
Documents
16
Period of Report
2023-03-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20230307.htm   iXBRL 8-K 45900
2 EX-1.1 exhibit11-amendmentno3toop.htm EX-1.1 24724
3 EX-5.1 exhibit51opinionofcooley.htm EX-5.1 6030
7 GRAPHIC exhibit51opinionofcooley001.jpg GRAPHIC 272344
8 GRAPHIC exhibit51opinionofcooley002.jpg GRAPHIC 95090
  Complete submission text file 0001628280-23-006626.txt   732112

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20230307.xsd EX-101.SCH 1941
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20230307_lab.xml EX-101.LAB 25133
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20230307_pre.xml EX-101.PRE 13080
10 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20230307_htm.xml XML 11309
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 23710991
SIC: 2836 Biological Products, (No Diagnostic Substances)